John Michael Williford

Title: John Michael Williford: Innovator in Nanoparticle Delivery Systems

Introduction

John Michael Williford is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of nanoparticle delivery systems for therapeutic applications. His innovative work focuses on enhancing the efficacy of nucleic acid delivery in vivo.

Latest Patents

Williford holds a patent for "Compositions of nucleic acid-containing nanoparticles for in vivo delivery." This patent describes compositions that include a polymeric micellar nanoparticle made from a block or graft copolymer. The copolymer consists of at least one polycationic polymer and one polyethylene glycol (PEG) polymer with an average molecular weight of less than 1 kDa. The invention also details methods for preparing these nanoparticles, targeting metastatic cancer cells, and treating diseases using the disclosed compositions. He has 1 patent to his name.

Career Highlights

Williford is affiliated with The Johns Hopkins University, where he continues to advance research in nanoparticle technology. His work is pivotal in developing new methods for drug delivery, which can significantly impact cancer treatment and other medical applications.

Collaborations

He has collaborated with esteemed colleagues such as Hai-Quan Mao and Maani Archang, contributing to a rich environment of innovation and research.

Conclusion

John Michael Williford's contributions to nanoparticle delivery systems exemplify the intersection of engineering and medicine. His work holds promise for improving therapeutic outcomes in various diseases, particularly cancer.